Goldman Sachs Downgrades AstraZeneca To Sell, Cites High Pipeline Expectations
April 12, 2016 at 07:57 AM EDT
The valuation of AstraZeneca plc (ADR) (NYSE: AZN) shares “skews the risk-reward against investors,” Goldman Sachs’ ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.